Insider transactions

EDGAR

ELI LILLY AND COMPANY

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
103 transactions, 784,302 shares
Sum of shares × price per share: 853,555,556.266

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 242

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-16 Filed 2026-11-17Hedley Mary Lynne Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)167.63641,431.67
240,000.004788

Derived: shares × price per share. Exact value 240000.004788.

2,429.9017Direct (D) No— Open filing 0001340823-26-000002 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17LUCIANO JUAN R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)11.11761,431.67
15,916.734392

Derived: shares × price per share. Exact value 15916.734392.

16,980.7639Direct (D) No
F1
  • F1 At the election of the reporting person, the shares reported as acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0000059478-26-000112 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17LUCIANO JUAN R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)167.63641,431.67
240,000.004788

Derived: shares × price per share. Exact value 240000.004788.

17,148.4003Direct (D) No— Open filing 0000059478-26-000112 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Kaelin William G Jr Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)167.63641,431.67
240,000.004788

Derived: shares × price per share. Exact value 240000.004788.

22,139.3689Direct (D) No— Open filing 0001551715-26-000002 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Moeller Jon R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)167.63641,431.67
240,000.004788

Derived: shares × price per share. Exact value 240000.004788.

473.021Direct (D) No— Open filing 0000059478-26-000116 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17JACKSON JAMERE Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)167.63641,431.67
240,000.004788

Derived: shares × price per share. Exact value 240000.004788.

9,861.2537Direct (D) No— Open filing 0000059478-26-000120 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Bertozzi Carolyn R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)177.74051,431.67
254,465.741635

Derived: shares × price per share. Exact value 254465.741635.

2,177.7405Direct (D) No— Open filing 0001698766-26-000008 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Fyrwald J Erik Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6.92661,431.67
9,916.605422

Derived: shares × price per share. Exact value 9916.605422.

75,551.0525Direct (D) No
F1
  • F1 At the election of the reporting person, the shares reported as acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0000059478-26-000110 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Fyrwald J Erik Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)167.63641,431.67
240,000.004788

Derived: shares × price per share. Exact value 240000.004788.

75,718.6889Direct (D) No— Open filing 0000059478-26-000110 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Sulzberger Gabrielle Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)3.46331,431.67
4,958.302711

Derived: shares × price per share. Exact value 4958.302711.

3,019.9082Direct (D) No
F1
  • F1 At the election of the reporting person, the shares reported as acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0001262388-26-000022 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Sulzberger Gabrielle Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)167.63641,431.67
240,000.004788

Derived: shares × price per share. Exact value 240000.004788.

3,187.5446Direct (D) No— Open filing 0001262388-26-000022 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17JOHNSON KIMBERLY H Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)167.63641,431.67
240,000.004788

Derived: shares × price per share. Exact value 240000.004788.

3,452.2788Direct (D) No— Open filing 0000059478-26-000114 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Alvarez Ralph Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8.67291,431.67
12,416.730743

Derived: shares × price per share. Exact value 12416.730743.

55,856.9028Direct (D) No
F1
  • F1 At the election of the reporting person, the shares reported as acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0001310215-26-000021 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Alvarez Ralph Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)167.63641,431.67
240,000.004788

Derived: shares × price per share. Exact value 240000.004788.

56,024.5392Direct (D) No— Open filing 0001310215-26-000021 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Baicker Katherine Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)167.63641,431.67
240,000.004788

Derived: shares × price per share. Exact value 240000.004788.

23,815.4982Direct (D) No— Open filing 0001537067-26-000002 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10Jonsson Patrik Officer: EVP President, LLY Int'l
G

Bona fide gift

Common Stock
Disposed (D)7040—53,442.62Direct (D) No— Open filing 0001786054-26-000008 Read from the filing’s XML Dispute this row
2026-11-03 Filed 2026-11-04Ricks David A Director · Officer: President, Chair, and CEO
G

Bona fide gift

Common Stock
Disposed (D)23,5380—555,278.097Direct (D) No
F1
  • F1 The amount reported includes (i) 4,990 shares of Eli Lilly and Company common stock transferred to the reporting person on May 14, 2026 as an annuity payment from the 2022 GRAT and (ii) 2,111 shares of Eli Lilly and Company common stock transferred to the reporting person on September 18, 2026 as an annuity payment from the 2025 GRAT, each a Grantor Retained Annuity Trust of which the reporting person is the trustee and each paid in accordance with its terms.
Open filing 0001538604-26-000006 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-03Hakim Anat Officer: EVP, GC Secretary
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,0001,402.52
7,012,600

Derived: shares × price per share. Exact value 7012600.00.

4,137.456Indirect (I) By spouseYes
F1, F2
  • F1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2026.
  • F2 The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
Open filing 0001685556-26-000008 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-03Skovronsky Daniel Officer: EVP, CSPO Pres. LRL
G

Bona fide gift

Common Stock
Disposed (D)1190—159,952.725Direct (D) No— Open filing 0001741474-26-000006 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Dozier Eric Officer: EVP, Chief People Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)2,3000—16,539.212Direct (D) No— Open filing 0001955972-26-000010 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Dozier Eric Officer: EVP, Chief People Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1,019.3611,417.54
1,444,984.99194

Derived: shares × price per share. Exact value 1444984.99194.

15,519.851Direct (D) No— Open filing 0001955972-26-000010 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Dozier Eric Officer: EVP, Chief People Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (2,300)
Disposed (D)2,3000—0Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Open filing 0001955972-26-000010 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Hernandez Edgardo Officer: EVP Pres., Mfg. Operations
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)2,5300—48,612.717Direct (D) No— Open filing 0001861052-26-000008 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Hernandez Edgardo Officer: EVP Pres., Mfg. Operations
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1,122.9021,417.54
1,591,758.50108

Derived: shares × price per share. Exact value 1591758.50108.

47,489.815Direct (D) No— Open filing 0001861052-26-000008 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Hernandez Edgardo Officer: EVP Pres., Mfg. Operations
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (2,530)
Disposed (D)2,5300—0Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Open filing 0001861052-26-000008 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Custer Kenneth L. Officer: EVP President, Card Met Hlth
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)3,2200—13,360.544Direct (D) No— Open filing 0002071542-26-000006 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Custer Kenneth L. Officer: EVP President, Card Met Hlth
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1,425.4471,417.54
2,020,628.14038

Derived: shares × price per share. Exact value 2020628.14038.

11,935.097Direct (D) No— Open filing 0002071542-26-000006 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Custer Kenneth L. Officer: EVP President, Card Met Hlth
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (3,220)
Disposed (D)3,2200—0Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Open filing 0002071542-26-000006 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Brown Adrienne S Officer: EVP, President LLY Imm
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)2,5300—10,992.579Direct (D) No— Open filing 0002096888-26-000008 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Brown Adrienne S Officer: EVP, President LLY Imm
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1,098.6561,417.54
1,557,388.82624

Derived: shares × price per share. Exact value 1557388.82624.

9,893.923Direct (D) No— Open filing 0002096888-26-000008 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Brown Adrienne S Officer: EVP, President LLY Imm
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (2,530)
Disposed (D)2,5300—0Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Open filing 0002096888-26-000008 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Montarce Lucas Officer: EVP CFO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)1,6100—17,868.473Direct (D) No— Open filing 0001752447-26-000006 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Montarce Lucas Officer: EVP CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)677.5931,417.54
960,515.18122

Derived: shares × price per share. Exact value 960515.18122.

17,190.88Direct (D) No— Open filing 0001752447-26-000006 Read from the filing’s XML Dispute this row
2026-11-01 Filed 2026-11-03Montarce Lucas Officer: EVP CFO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (1,610)
Disposed (D)1,6100—0Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Open filing 0001752447-26-000006 Read from the filing’s XML Dispute this row
2026-10-19 Filed 2026-10-20Fyrwald J Erik Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)7.99511,240.34
9,916.642334

Derived: shares × price per share. Exact value 9916.642334.

75,544.1259Direct (D) No
F1
  • F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0000059478-26-000097 Read from the filing’s XML Dispute this row
2026-10-19 Filed 2026-10-20Sulzberger Gabrielle Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)3.99761,240.34
4,958.383184

Derived: shares × price per share. Exact value 4958.383184.

3,016.4449Direct (D) No
F1
  • F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0001262388-26-000020 Read from the filing’s XML Dispute this row
2026-10-19 Filed 2026-10-20Alvarez Ralph Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)10.01071,240.34
12,416.671638

Derived: shares × price per share. Exact value 12416.671638.

55,848.2299Direct (D) No
F1
  • F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0001310215-26-000019 Read from the filing’s XML Dispute this row
2026-10-19 Filed 2026-10-20LUCIANO JUAN R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)12.83251,240.34
15,916.66305

Derived: shares × price per share. Exact value 15916.663050.

16,969.6463Direct (D) No
F1
  • F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0000059478-26-000099 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-22Sulzberger Gabrielle Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4.25651,164.89
4,958.354285

Derived: shares × price per share. Exact value 4958.354285.

3,012.4473Direct (D) No
F1
  • F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0001262388-26-000018 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-22Alvarez Ralph Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)10.65911,164.89
12,416.678999

Derived: shares × price per share. Exact value 12416.678999.

55,838.2192Direct (D) No
F1
  • F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0001310215-26-000017 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-22Fyrwald J Erik Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8.5131,164.89
9,916.70857

Derived: shares × price per share. Exact value 9916.70857.

75,536.1308Direct (D) No
F1
  • F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0000059478-26-000089 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-22LUCIANO JUAN R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)13.66371,164.89
15,916.707493

Derived: shares × price per share. Exact value 15916.707493.

16,956.8138Direct (D) No
F1
  • F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0000059478-26-000091 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-11Seymour Melissa Officer: EVP, Global Quality
G

Bona fide gift

Common Stock
Disposed (D)120—1,038.373Direct (D) No— Open filing 0002032089-26-000004 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Hernandez Edgardo Officer: EVP Pres., Mfg. Operations
G

Bona fide gift

Common Stock
Disposed (D)130—46,082.717Direct (D) No— Open filing 0001861052-26-000006 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Dozier Eric Officer: EVP, Chief People Officer
G

Bona fide gift

Common Stock
Disposed (D)2160—14,239.212Direct (D) No— Open filing 0001955972-26-000008 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-18LUCIANO JUAN R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)13.45271,183.16
15,916.696532

Derived: shares × price per share. Exact value 15916.696532.

16,918.0448Direct (D) No
F1
  • F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0000059478-26-000087 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-18Jonsson Patrik Officer: EVP President, LLY Int'l
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6,5001,175.10
7,638,150

Derived: shares × price per share. Exact value 7638150.00.

54,146.62Direct (D) Yes
F1
  • F1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2026
Open filing 0001786054-26-000006 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-18Fyrwald J Erik Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8.38151,183.16
9,916.65554

Derived: shares × price per share. Exact value 9916.655540.

75,418.1248Direct (D) No
F1
  • F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0000059478-26-000085 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-18Alvarez Ralph Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)10.49451,183.16
12,416.67262

Derived: shares × price per share. Exact value 12416.672620.

55,744.788Direct (D) No
F1
  • F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0001310215-26-000015 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-18Sulzberger Gabrielle Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4.19081,183.16
4,958.386928

Derived: shares × price per share. Exact value 4958.386928.

3,003.9096Direct (D) No
F1
  • F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Open filing 0001262388-26-000016 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–50 of 4,811

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
LILLY ENDOWMENT INC 90,066,978 SH104,214,698,904 dollarsLower by 310,000 Prior quarter: 90,376,978Open filing 0000316011-26-000034 Filed 2026-10-19 Dispute this row
BlackRock, Inc. Partly reported under another manager67,936,153 SH78,607,563,355 dollarsHigher by 395,753 Prior quarter: 67,540,400Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 53,921,209 SH62,391,152,510 dollarsHigher by 392,341 Prior quarter: 53,528,868Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
PNC Financial Services Group, Inc. Partly reported under another manager51,295,197 SH59,352,646,400 dollarsLower by 27,523 Prior quarter: 51,322,720Open filing 0001193125-26-450808 Filed 2026-11-06 Dispute this row
STATE STREET CORP Partly reported under another manager36,848,565 SH42,636,737,590 dollarsHigher by 632,811 Prior quarter: 36,215,754Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
FMR LLC Partly reported under another manager29,959,147 SH34,665,130,320 dollarsHigher by 1,496,672 Prior quarter: 28,462,475Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 20,999,744 SH24,298,383,788 dollarsHigher by 140,527 Prior quarter: 20,859,217Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager20,556,572 SH23,722,722,425 dollarsHigher by 245,714 Prior quarter: 20,310,858Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Capital Research Global Investors Partly reported under another manager16,998,595 SH19,670,092,948 dollarsLower by 3,874,545 Prior quarter: 20,873,140Open filing 0001422848-26-000129 Filed 2026-11-12 Dispute this row
MORGAN STANLEY Partly reported under another manager16,377,649 SH18,950,253,444 dollarsHigher by 151,251 Prior quarter: 16,226,398Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Capital World Investors Partly reported under another manager15,806,412 SH18,291,047,426 dollarsLower by 96,230 Prior quarter: 15,902,642Open filing 0001422849-26-000169 Filed 2026-11-12 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager13,785,955 SH16,331,259,062 dollarsHigher by 1,187,431 Prior quarter: 12,598,524Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager13,383,370 SH15,485,631 dollarsLower by 528,469 Prior quarter: 13,911,839Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager11,048,493 SH12,783,990,282 dollarsHigher by 49,540 Prior quarter: 10,998,953Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager11,029,526 SH12,762,043,790 dollarsLower by 244,717 Prior quarter: 11,274,243Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO Partly reported under another manager10,759,188 SH12,449,241,251 dollarsUnchanged Prior quarter: 10,759,188Open filing 0000315032-26-000005 Filed 2026-11-12 Dispute this row
PRIMECAP MANAGEMENT CO/CA/ 9,083,636 SH10,510,493,545 dollarsLower by 89,268 Prior quarter: 9,172,904Open filing 0000763212-26-000037 Filed 2026-11-12 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager8,788,679 SH10,169,204,697 dollarsLower by 8,187 Prior quarter: 8,796,866Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Partly reported under another manager8,375,693 SH9,691,346,859 dollarsHigher by 1,166,308 Prior quarter: 7,209,385Open filing 0000861177-26-000005 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager6,859,116 SH7,936,545,915 dollarsLower by 793,844 Prior quarter: 7,652,960Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 5,844,849 SH6,762,957,992 dollarsLower by 157,106 Prior quarter: 6,001,955Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
Capital International Investors Partly reported under another manager5,716,700 SH6,615,888,594 dollarsLower by 18,068 Prior quarter: 5,734,768Open filing 0001562230-26-000136 Filed 2026-11-12 Dispute this row
Nuveen, LLC Partly reported under another manager5,463,732 SH6,321,975,272 dollarsHigher by 402,222 Prior quarter: 5,061,510Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
Fisher Asset Management, LLC Partly reported under another manager5,424,027 SH6,276,033,816 dollarsHigher by 360,511 Prior quarter: 5,063,516Open filing 0000850529-26-000009 Filed 2026-11-06 Dispute this row
JENNISON ASSOCIATES LLC Partly reported under another manager5,312,305 SH6,146,761,287 dollarsLower by 149,111 Prior quarter: 5,461,416Open filing 0000053417-26-000068 Filed 2026-11-16 Dispute this row
Legal General Group Plc Partly reported under another manager5,261,017 SH6,087,417,549 dollarsHigher by 115,788 Prior quarter: 5,145,229Open filing 0001495115-26-000075 Filed 2026-11-16 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager4,745,900 SH5,491,386,649 dollarsLower by 37,559 Prior quarter: 4,783,459Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
VANGUARD FIDUCIARY TRUST CO 4,661,866 SH5,394,151,911 dollarsHigher by 69,555 Prior quarter: 4,592,311Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Amundi Partly reported under another manager4,655,456 SH5,386,764,738 dollarsLower by 152,687 Prior quarter: 4,808,143Open filing 0001172661-26-004884 Filed 2026-11-06 Dispute this row
WELLS FARGO COMPANY/MN Partly reported under another manager4,615,352 SH5,340,332,385 dollarsLower by 30,767 Prior quarter: 4,646,119Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row
ROYAL BANK OF CANADA Partly reported under another manager4,138,991 SH4,789,143,000 dollarsLower by 219,410 Prior quarter: 4,358,401Open filing 0001140361-26-044123 Filed 2026-11-16 Dispute this row
ALLIANCEBERNSTEIN L.P. Partly reported under another manager3,978,703 SH4,604,389,422 dollarsLower by 282,682 Prior quarter: 4,261,385Open filing 0001109448-26-000342 Filed 2026-11-16 Dispute this row
Janus Henderson Group Ltd. Partly reported under another manager3,925,280 SH4,542,607,749 dollarsNot in the prior quarter’s filings read Open filing 0001085146-26-000952 Filed 2026-11-16 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager3,889,092 SH4,500,650,320 dollarsLower by 114,325 Prior quarter: 4,003,417Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager3,886,941 SH5,511,660,641 dollarsLower by 703,277 Prior quarter: 4,590,218Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
Invesco Ltd. Partly reported under another manager3,827,039 SH4,428,191,130 dollarsHigher by 132,887 Prior quarter: 3,694,152Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager3,795,355 SH4,391,529,363 dollarsHigher by 415,728 Prior quarter: 3,379,627Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
UBS Group AG Partly reported under another manager3,718,237 SH4,302,297,669 dollarsLower by 147,694 Prior quarter: 3,865,931Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Put Partly reported under another manager3,384,900 SH3,916,600,092 dollarsHigher by 172,200 Prior quarter: 3,212,700Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager3,111,700 SH3,600,485,836 dollarsLower by 657,800 Prior quarter: 3,769,500Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager3,073,253 SH3,555,414,757 dollarsHigher by 76,584 Prior quarter: 2,996,669Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager3,000,403 SH3,471,713,908 dollarsHigher by 645,566 Prior quarter: 2,354,837Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row
Swiss National Bank 2,189,430 SH2,533,345,664 dollarsLower by 75,720 Prior quarter: 2,265,150Open filing 0001582202-26-000008 Filed 2026-11-12 Dispute this row
UBS Group AG Option: Call Partly reported under another manager2,184,554 SH2,527,703,742 dollarsLower by 5,115,828 Prior quarter: 7,300,382Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
JANE STREET GROUP, LLC Option: Put Partly reported under another manager2,157,400 SH2,496,284,392 dollarsLower by 359,000 Prior quarter: 2,516,400Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
VICTORY CAPITAL MANAGEMENT INC 2,155,926 SH2,494,654,504 dollarsHigher by 14,479 Prior quarter: 2,141,447Open filing 0001040188-26-000051 Filed 2026-11-10 Dispute this row
Mitsubishi UFJ Asset Management Co., Ltd. Partly reported under another manager2,146,752 SH2,483,963,804 dollarsHigher by 133,056 Prior quarter: 2,013,696Open filing 0001193125-26-447983 Filed 2026-11-05 Dispute this row
JANE STREET GROUP, LLC Option: Call Partly reported under another manager2,058,600 SH2,381,964,888 dollarsLower by 56,300 Prior quarter: 2,114,900Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
CITADEL ADVISORS LLC Option: Call Partly reported under another manager2,020,800 SH2,338,227,264 dollarsHigher by 139,300 Prior quarter: 1,881,500Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
HSBC HOLDINGS PLC Partly reported under another manager2,017,503 SH2,345,984,037 dollarsHigher by 28,908 Prior quarter: 1,988,595Open filing 0000873630-26-000005 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • NORGES BANK 11,471,413 SH
  • Sixth Street Partners Management Company, L.P. 6,001,955 SH
  • Jupiter Topco LLC 3,891,118 SH
  • SG Americas Securities, LLC 1,983,708 SH
  • Tredje AP-fonden 257,172 SH
  • Hudson Bay Capital Management LP 100,000 SH
  • Hudson Bay Capital Management LP 100,000 SH
  • SG Americas Securities, LLC 95,000 SH
  • Quadrature Capital Ltd 75,764 SH
  • SG Americas Securities, LLC 74,200 SH
  • NewEdge Wealth, LLC 64,986 SH
  • Pacer Advisors, Inc. 59,898 SH
  • VOLORIDGE INVESTMENT MANAGEMENT, LLC 56,499 SH
  • HM PAYSON CO 53,616 SH
  • ADAPT Investment Managers SA 50,000 SH
  • Envestnet Portfolio Solutions, Inc. 41,689 SH
  • Catalyst Funds Management Pty Ltd 38,081 SH
  • SAMLYN CAPITAL, LLC 37,125 SH
  • Financial Gravity Companies, Inc. 34,069 SH
  • Stillwater Capital Advisors, LLC 33,909 SH
  • JOHNSON INVESTMENT COUNSEL INC 33,088 SH
  • Arkadios Wealth Advisors 32,277 SH
  • DLD Asset Management, LP 30,500 SH
  • Susquehanna Portfolio Strategies, LLC 29,264 SH
  • Summit Trail Advisors, LLC 29,075 SH
  • World Investment Advisors 25,879 SH
  • Valiant Capital Management, L.P. 24,286 SH
  • Venturi Wealth Management, LLC 23,196 SH
  • Longaeva Partners L.P. 20,808 SH
  • SPIREPOINT PRIVATE CLIENT, LLC 20,170 SH
  • Eversept Partners, LP 20,116 SH
  • Affinity Asset Advisors, LLC 20,000 SH
  • ADAPT Investment Managers SA 20,000 SH
  • Science Technology Partners, L.P. 19,550 SH
  • Arete Wealth Advisors, LLC 19,442 SH
  • Holistic Financial Partners 19,363 SH
  • Wahed Invest LLC 18,964 SH
  • Warther Private Wealth, LLC 17,266 SH
  • ROWLANDMILLER PARTNERS.ADV 15,075 SH
  • Integral Health Asset Management, LLC 15,000 SH
  • Lodge Hill Capital, LLC 15,000 SH
  • ExodusPoint Capital Management, LP 14,472 SH
  • RNC CAPITAL MANAGEMENT LLC 13,549 SH
  • Silicon Valley Capital Partners 13,489 SH
  • Militia Capital Management LLC 12,800 SH
  • American Financial Advisors, LLC 12,501 SH
  • DRW Securities, LLC 12,500 SH
  • WELLS FARGO COMPANY/MN 12,500 SH
  • Arini Capital Management Ltd 12,000 SH
  • CAISSE DES DEPOTS ET CONSIGNATIONS 11,381 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

Showing 1–50 of 165

House members’ trades in this company, newest report first, as filed
MemberTransaction dateTypeAmountOwnerReport
Hon. David J. Taylor (OH02)2026-11-03Sale$1,001 - $15,0002026-11-12
Hon. David J. Taylor (OH02)2026-11-03Sale$1,001 - $15,0002026-11-12
Hon. Gilbert Cisneros (CA31)2026-10-20Purchase$1,001 - $15,0002026-11-10
Hon. Michael Rulli (OH06)2025-12-02Sale$1,001 - $15,0002026-08-07
Hon. Michael Rulli (OH06)2026-07-01Sale$1,001 - $15,0002026-08-07
Hon. Michael Rulli (OH06)2026-01-02Purchase$1,001 - $15,0002026-08-07
Hon. Dan Newhouse (WA04)2026-07-10Sale (partial)$1,001 - $15,000SP2026-07-17
Hon. Gilbert Cisneros (CA31)2026-06-10Purchase$50,001 - $100,0002026-07-02
Hon. Byron Donalds (FL19)2026-04-02Purchase$1,001 - $15,000SP2026-05-13
Hon. Byron Donalds (FL19)2026-04-02Purchase$1,001 - $15,0002026-05-13
Hon. Gilbert Cisneros (CA31)2026-04-14Purchase$1,001 - $15,0002026-05-08
Hon. Elizabeth Fletcher (TX07)2026-04-08Sale (partial)$1,001 - $15,0002026-05-01
Hon. Gilbert Cisneros (CA31)2026-03-13Sale (partial)$1,001 - $15,0002026-04-07
Hon. David J. Taylor (OH02)2026-02-26Purchase$1,001 - $15,0002026-03-06
Hon. David J. Taylor (OH02)2026-02-09Sale$1,001 - $15,0002026-02-20
Hon. David J. Taylor (OH02)2026-01-16Sale$1,001 - $15,0002026-02-02
Hon. Julie Johnson (TX32)2025-12-18Sale$1,001 - $15,000JT2026-01-15
Hon. David J. Taylor (OH02)2025-12-10Sale$1,001 - $15,0002025-12-19
Hon. Gilbert Cisneros (CA31)2025-11-18Purchase$1,001 - $15,0002025-12-15
Hon. Julie Johnson (TX32)2025-11-13Sale (partial)$1,001 - $15,000JT2025-12-11
Hon. Valerie Hoyle (OR04)2025-09-23Sale$1,001 - $15,000SP2025-10-10
Hon. Valerie Hoyle (OR04)2025-05-06Sale (partial)$1,001 - $15,000SP2025-09-12
Hon. Valerie Hoyle (OR04)2024-10-29Purchase$1,001 - $15,000SP2025-09-12
Hon. Julie Johnson (TX32)2025-08-14Sale (partial)$1,001 - $15,000JT2025-09-11
Hon. David J. Taylor (OH02)2025-08-14Purchase$15,001 - $50,0002025-09-02
Hon. David J. Taylor (OH02)2025-08-14Purchase$1,001 - $15,0002025-09-02
Hon. Jonathan Jackson (IL01)2025-05-21Sale$1,001 - $15,000SP2025-08-25
Hon. Jonathan Jackson (IL01)2025-04-23Purchase$1,001 - $15,000SP2025-08-25
Hon. Lisa McClain (MI09)2025-07-10Purchase$1,001 - $15,000SP2025-08-13
Hon. Lisa McClain (MI09)2025-07-16Sale$1,001 - $15,000SP2025-08-13
Hon. Lisa McClain (MI09)2025-06-09Sale (partial)$1,001 - $15,000SP2025-08-13
Hon. Lisa McClain (MI09)2024-12-11Purchase$1,001 - $15,000SP2025-08-13
Hon. Jonathan Jackson (IL01)2025-06-03Sale$15,001 - $50,000JT2025-07-14
Hon. Jefferson Shreve (IN06)2025-05-12Sale$100,001 - $250,0002025-06-22
Hon. Josh Gottheimer (NJ05)2025-05-01Purchase$1,001 - $15,000JT2025-06-11
Hon. Josh Gottheimer (NJ05)2025-05-13Sale (partial)$1,001 - $15,000JT2025-06-11
Hon. Gilbert Cisneros (CA31)2025-05-30Sale (partial)$1,001 - $15,0002025-06-06
Hon. Marjorie Taylor Greene (GA14)2025-05-14Purchase$1,001 - $15,0002025-05-19
Hon. Dan Newhouse (WA04)2025-04-11Sale (partial)$1,001 - $15,000SP2025-05-16
Hon. Julie Johnson (TX32)2025-04-07Sale$1,001 - $15,000JT2025-05-14
Hon. Josh Gottheimer (NJ05)2025-04-09Sale (partial)$1,001 - $15,000JT2025-05-14
Hon. Jonathan Jackson (IL01)2025-04-21Purchase$15,001 - $50,000JT2025-05-13
Hon. Bruce Westerman (AR04)2025-04-21Sale$1,001 - $15,0002025-05-12
Hon. Marjorie Taylor Greene (GA14)2025-05-05Purchase$1,001 - $15,0002025-05-06
Hon. Rob Bresnahan (PA08)2025-04-08Sale$1,001 - $15,0002025-04-28
Hon. Bruce Westerman (AR04)2025-03-03Purchase$1,001 - $15,0002025-04-16
Hon. Josh Gottheimer (NJ05)2025-03-10Sale (partial)$1,001 - $15,000JT2025-04-10
Hon. Josh Gottheimer (NJ05)2025-02-19Sale (partial)$1,001 - $15,000JT2025-03-06
Hon. Josh Gottheimer (NJ05)2025-01-08Sale (partial)$1,001 - $15,000JT2025-02-10
Hon. Marjorie Taylor Greene (GA14)2025-01-21Purchase$1,001 - $15,0002025-01-27

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
LILLY ENDOWMENT, INC. Common Stock, Without Par Value9.690,066,978.0009/30/2026 Filed 2026-10-19SCHEDULE 13G/AAmendment 47Open filing 0000316011-26-000036 Dispute this row
LILLY ENDOWMENT, INC. Common Stock, Without Par Value9.690,376,978.0006/30/2026 Filed 2026-07-23SCHEDULE 13G/AAmendment 46Open filing 0000316011-26-000029 Dispute this row
Vanguard Capital Management Common Stock6.4861,295,60503/31/2026 Filed 2026-05-01SCHEDULE 13GOpen filing 0002100119-26-001290 Dispute this row
LILLY ENDOWMENT, INC. Common Stock, Without Par Value9.791,896,978.0003/31/2026 Filed 2026-04-20SCHEDULE 13G/AAmendment 45Open filing 0000316011-26-000011 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-26SCHEDULE 13G/AAmendment 10Open filing 0000102909-26-001113 Dispute this row
LILLY ENDOWMENT, INC. Common Stock, Without Par Value9.892,190,516.0012/31/2025 Filed 2026-01-23SCHEDULE 13G/AAmendment 44Open filing 0000316011-26-000007 Dispute this row
LILLY ENDOWMENT, INC. Common Stock, Without Par Value10.195,492,993.0009/30/2025 Filed 2025-10-30SCHEDULE 13G/AAmendment 43Open filing 0000316011-25-000041 Dispute this row
The Vanguard Group Common Stock8.5580,952,59509/30/2025 Filed 2025-10-30SCHEDULE 13G/AAmendment 9Open filing 0000102909-25-000087 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,626,574 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201543,661
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,123

Filings made before the SEC required XML are listed, not extracted.

Back to ELI LILLY AND COMPANY